Oral Rivaroxaban Reduces VTE in Outpatient Treatment of Patients With Cancer - https://t.co/iMuaUbWW8m https://t.co/hfuPTbvGhI
— IDRO (@IDROOhio) March 9, 2019
from Twitter https://twitter.com/IDROOhio
March 09, 2019 at 01:32AM
Saturday, March 9, 2019
Oral Rivaroxaban Reduces VTE in Outpatient Treatment of Patients With Cancer - https://t.co/iMuaUbWW8m https://t.co/hfuPTbvGhI
from Twitter https://twitter.com/IDROOhio
March 09, 2019 at 01:32AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment